"Dormant" Drug Candidates Eligible For Exclusivity Incentives In Draft Bill
This article was originally published in The Pink Sheet Daily
Executive Summary
Bill floated by the National Health Council would promote development of therapies that have the potential to address an unmet medical need but are viewed by the biopharma industry as unattractive candidates because they have insufficient patent protection.